 DUBLIN, Feb. 9, 2021 PRNewswire -- Theravance Biopharma, Inc. NASDAQ: TBPH, a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will report its fourth quarter and full year 2020 financial results... 